HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jan Aagaard Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andersen, P. V Articles by Aagaard, J. Search for Related Content PubMed Articles by Andersen, P. V Articles by Aagaard, J.

Low-Dose Warfarin in Patients With Carbomedics Heart Valve Prostheses

Department of Cardiothoracic and Vascular Surgery Odense University Hospital Odense, Denmark

For reprint information contact: Jan Aagaard, MD Tel: 45 6541 1853 Fax: 45 6591 6935 email: jan.aagaard{at}ouh.dk Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense C, DK-5000, Denmark.

All patients who received a Carbomedics heart valve prosthesis were assessed retrospectively by interview regarding thromboembolic, hemorrhagic, or other valve-related events. In cases of such events, the patient's practitioner or cardiologist was interviewed. Hospital records were reviewed in cases of hospital admission. Included in the study were patients who had isolated replacement of the aortic or mitral valve in whom it was possible to collect all International Normalized Ratio values from discharge through follow-up. There were 148 patients with isolated aortic valve replacement and 56 with isolated mitral valve replacement. Bleeding events were 3 times more frequent than thromboembolic events. Based on our results we will apply an International Normalized Ratio between 2 and 2.5 for patients with a Carbomedics heart valve prosthesis in aortic position and ratios between 2.5 and 3 for those with a mitral valve prosthesis.

This article has been cited by other articles:

				N. Oake MSc, A. Jennings MA, A. J. Forster MD MSc, D. Fergusson PhD, S. Doucette MSc, and C. van Walraven MD MSc Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis Can. Med. Assoc. J., July 29, 2008; 179(3): 235 - 244. [Abstract] [Full Text] [PDF]

				V. Pengo, G. Palareti, U. Cucchini, M. Molinatti, R. Del Bono, F. Baudo, A. Ghirarduzzi, C. Pegoraro, and S. Iliceto Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP) Clinical and Applied Thrombosis/Hemostasis, July 1, 2007; 13(3): 241 - 248. [Abstract] [PDF]

				N. Oake, D. A. Fergusson, A. J. Forster, and C. van Walraven Frequency of adverse events in patients with poor anticoagulation: a meta-analysis Can. Med. Assoc. J., May 22, 2007; 176(11): 1589 - 1594. [Abstract] [Full Text] [PDF]